Axsome Therapeutics Stock Price History
| AXSM Stock | USD 126.27 0.37 0.29% |
Below is the normalized historical share price chart for Axsome Therapeutics extending back to November 19, 2015. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Axsome Therapeutics stands at 126.27, as last reported on the 21st of March, with the highest price reaching 126.27 and the lowest price hitting 125.90 during the day.
If you're considering investing in Axsome Stock, it is important to understand the factors that can impact its price. Axsome Therapeutics appears to be very steady, given 3 months investment horizon. Axsome Therapeutics secures Sharpe Ratio (or Efficiency) of 0.17, which signifies that the company had a 0.17 % return per unit of risk over the last 3 months. By analyzing Axsome Therapeutics' technical indicators, you can evaluate if the expected return of 0.71% is justified by implied risk. Please makes use of Axsome Therapeutics' Risk Adjusted Performance of 0.1086, mean deviation of 2.65, and Downside Deviation of 2.35 to double-check if our risk estimates are consistent with your expectations.
At this time, Axsome Therapeutics' Total Stockholder Equity is very stable compared to the past year. As of the 21st of March 2025, Liabilities And Stockholders Equity is likely to grow to about 596.9 M, while Common Stock Shares Outstanding is likely to drop about 32 M. . At this time, Axsome Therapeutics' Price Book Value Ratio is very stable compared to the past year. As of the 21st of March 2025, Price To Book Ratio is likely to grow to 74.66, while Price Earnings Ratio is likely to drop (14.82). Axsome Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 19th of November 2015 | 200 Day MA 94.1564 | 50 Day MA 113.6623 | Beta 0.996 |
Axsome |
Sharpe Ratio = 0.1738
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | AXSM | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.1 actual daily | 36 64% of assets are more volatile |
Expected Return
| 0.71 actual daily | 14 86% of assets have higher returns |
Risk-Adjusted Return
| 0.17 actual daily | 13 87% of assets perform better |
Based on monthly moving average Axsome Therapeutics is performing at about 13% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Axsome Therapeutics by adding it to a well-diversified portfolio.
Price Book 107.6833 | Enterprise Value Ebitda (14.81) | Price Sales 15.9183 | Shares Float 36.7 M | Wall Street Target Price 173 |
Axsome Therapeutics Stock Price History Chart
There are several ways to analyze Axsome Stock price data. The simplest method is using a basic Axsome candlestick price chart, which shows Axsome Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | February 21, 2025 | 137.75 |
| Lowest Price | January 10, 2025 | 80.05 |
Axsome Therapeutics March 21, 2025 Stock Price Synopsis
Various analyses of Axsome Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Axsome Stock. It can be used to describe the percentage change in the price of Axsome Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Axsome Stock.| Axsome Therapeutics Price Action Indicator | 0.37 | |
| Axsome Therapeutics Price Daily Balance Of Power | 1.00 | |
| Axsome Therapeutics Price Rate Of Daily Change | 1.00 |
Axsome Therapeutics March 21, 2025 Stock Price Analysis
Axsome Stock Price History Data
The price series of Axsome Therapeutics for the period between Sat, Dec 21, 2024 and Fri, Mar 21, 2025 has a statistical range of 57.7 with a coefficient of variation of 16.31. The prices are distributed with arithmetic mean of 107.75. The median price for the last 90 days is 106.46.| Open | High | Low | Close | Volume | ||
03/21/2025 | 125.90 | 126.27 | 125.90 | 126.27 | ||
03/21/2025 | 125.90 | 126.27 | 123.51 | 126.27 | ||
| 03/19/2025 | 124.04 | 126.22 | 123.51 | 125.90 | 371,704 | |
| 03/18/2025 | 124.50 | 125.62 | 123.00 | 124.76 | 357,815 | |
| 03/17/2025 | 122.68 | 126.94 | 121.90 | 125.68 | 458,938 | |
| 03/14/2025 | 122.32 | 123.47 | 120.52 | 121.91 | 432,162 | |
| 03/13/2025 | 119.59 | 122.86 | 118.10 | 121.65 | 429,279 | |
| 03/12/2025 | 119.97 | 122.51 | 118.73 | 119.45 | 697,073 | |
| 03/11/2025 | 120.00 | 122.00 | 117.67 | 119.50 | 824,706 | |
| 03/10/2025 | 120.72 | 121.43 | 116.00 | 118.78 | 693,440 | |
| 03/07/2025 | 124.96 | 124.96 | 121.02 | 122.17 | 509,832 | |
| 03/06/2025 | 123.51 | 126.70 | 123.35 | 124.41 | 554,307 | |
| 03/05/2025 | 125.57 | 128.43 | 124.94 | 125.10 | 399,387 | |
| 03/04/2025 | 125.84 | 127.22 | 122.70 | 125.57 | 795,390 | |
| 03/03/2025 | 130.00 | 130.11 | 125.92 | 127.15 | 836,162 | |
| 02/28/2025 | 126.41 | 128.77 | 126.03 | 127.54 | 851,283 | |
| 02/27/2025 | 129.53 | 130.03 | 126.40 | 126.41 | 587,419 | |
| 02/26/2025 | 128.09 | 130.95 | 126.43 | 128.33 | 786,419 | |
| 02/25/2025 | 130.88 | 131.99 | 124.07 | 127.09 | 1,231,765 | |
| 02/24/2025 | 137.76 | 137.76 | 129.23 | 130.72 | 1,153,907 | |
| 02/21/2025 | 130.04 | 139.13 | 128.39 | 137.75 | 1,539,207 | |
| 02/20/2025 | 128.13 | 129.41 | 125.88 | 129.10 | 706,907 | |
| 02/19/2025 | 128.81 | 130.52 | 124.52 | 126.96 | 871,235 | |
| 02/18/2025 | 124.66 | 130.15 | 124.04 | 128.09 | 1,563,833 | |
| 02/14/2025 | 131.61 | 132.12 | 129.35 | 131.15 | 1,064,119 | |
| 02/13/2025 | 131.75 | 132.14 | 128.27 | 131.68 | 593,717 | |
| 02/12/2025 | 131.00 | 133.10 | 128.26 | 131.55 | 1,109,999 | |
| 02/11/2025 | 129.10 | 134.19 | 128.00 | 132.20 | 1,639,575 | |
| 02/10/2025 | 123.44 | 132.25 | 116.81 | 127.08 | 4,404,977 | |
| 02/07/2025 | 109.00 | 110.00 | 105.51 | 105.76 | 868,718 | |
| 02/06/2025 | 113.67 | 114.06 | 109.35 | 109.50 | 717,196 | |
| 02/05/2025 | 113.49 | 114.00 | 112.00 | 114.00 | 866,571 | |
| 02/04/2025 | 108.52 | 113.33 | 108.00 | 112.92 | 825,624 | |
| 02/03/2025 | 106.00 | 108.82 | 103.98 | 107.43 | 966,048 | |
| 01/31/2025 | 109.77 | 110.28 | 105.57 | 106.46 | 998,282 | |
| 01/30/2025 | 105.27 | 111.51 | 104.30 | 108.85 | 1,202,539 | |
| 01/29/2025 | 103.54 | 105.48 | 102.59 | 105.14 | 698,979 | |
| 01/28/2025 | 102.70 | 105.00 | 100.93 | 102.46 | 903,575 | |
| 01/27/2025 | 102.94 | 105.64 | 102.02 | 102.69 | 733,465 | |
| 01/24/2025 | 103.90 | 105.00 | 102.07 | 103.11 | 854,536 | |
| 01/23/2025 | 102.56 | 104.10 | 101.60 | 103.89 | 1,038,641 | |
| 01/22/2025 | 96.19 | 102.74 | 95.35 | 102.27 | 1,237,549 | |
| 01/21/2025 | 93.08 | 98.50 | 91.95 | 96.18 | 1,068,268 | |
| 01/17/2025 | 94.02 | 94.89 | 91.81 | 91.94 | 808,604 | |
| 01/16/2025 | 93.92 | 95.36 | 92.75 | 93.69 | 1,162,765 | |
| 01/15/2025 | 86.08 | 95.11 | 86.07 | 93.75 | 1,149,198 | |
| 01/14/2025 | 88.72 | 90.03 | 84.54 | 84.60 | 772,372 | |
| 01/13/2025 | 82.25 | 89.68 | 80.98 | 89.27 | 1,879,223 | |
| 01/10/2025 | 81.64 | 82.54 | 79.19 | 80.05 | 1,207,914 | |
| 01/08/2025 | 83.44 | 85.14 | 82.31 | 82.57 | 655,015 | |
| 01/07/2025 | 85.87 | 87.53 | 83.44 | 83.78 | 555,434 | |
| 01/06/2025 | 85.53 | 87.09 | 84.03 | 85.13 | 777,056 | |
| 01/03/2025 | 87.74 | 89.33 | 86.02 | 86.45 | 933,533 | |
| 01/02/2025 | 85.25 | 90.31 | 84.93 | 87.32 | 1,158,318 | |
| 12/31/2024 | 84.48 | 85.46 | 83.12 | 84.61 | 1,088,317 | |
| 12/30/2024 | 82.00 | 84.98 | 75.56 | 84.78 | 3,533,545 | |
| 12/27/2024 | 86.24 | 87.88 | 85.26 | 86.70 | 588,958 | |
| 12/26/2024 | 86.50 | 88.59 | 84.94 | 87.97 | 432,741 | |
| 12/24/2024 | 86.34 | 87.38 | 85.29 | 87.01 | 254,897 | |
| 12/23/2024 | 90.00 | 90.06 | 85.10 | 86.95 | 816,248 | |
| 12/20/2024 | 88.82 | 93.12 | 87.69 | 90.73 | 956,383 |
About Axsome Therapeutics Stock history
Axsome Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Axsome is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Axsome Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Axsome Therapeutics stock prices may prove useful in developing a viable investing in Axsome Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 47.9 M | 32 M | |
| Net Loss | -168.4 M | -160 M |
Axsome Therapeutics Quarterly Net Working Capital |
|
Axsome Therapeutics Stock Technical Analysis
Axsome Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Sync Your Broker Now
Sync Your BrokerSync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |
| All Next | Launch Module |
Axsome Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Axsome Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Axsome Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Axsome to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1086 | |||
| Jensen Alpha | 0.51 | |||
| Total Risk Alpha | 0.7928 | |||
| Sortino Ratio | 0.2236 | |||
| Treynor Ratio | 0.5673 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Axsome Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. To learn how to invest in Axsome Stock, please use our How to Invest in Axsome Therapeutics guide.You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Axsome Therapeutics. If investors know Axsome will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Axsome Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.99) | Revenue Per Share | Quarterly Revenue Growth 0.66 | Return On Assets | Return On Equity |
The market value of Axsome Therapeutics is measured differently than its book value, which is the value of Axsome that is recorded on the company's balance sheet. Investors also form their own opinion of Axsome Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Axsome Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Axsome Therapeutics' market value can be influenced by many factors that don't directly affect Axsome Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Axsome Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Axsome Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Axsome Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.